New approaches to enzyme replacement therapy for Pompe disease
Leslie P. Cousens(Providence College), Anne S. De Groot(Providence College), William Martin(Emory University), David W. Scott(Spinal Cord Injury BC), Yan Su(Uniformed Services University of the Health Sciences), Federico Mingozzi(Spark Therapeutics (United States)), Sander van der Marel(Medisch Centrum Haaglanden), Valérie Ferreira(UniQure (Netherlands)), Richard D. Garman(Providence College)
Unknown
January 1, 2012
Cited by 0
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
|Proceedings of the National Academy of Sciences|2014|435
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
|Science Translational Medicine|2013|346
Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell–Cancer-Associated Fibroblast Interactions during Collective Invasion
|Clinical Cancer Research|2017|233
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
|Journal of Clinical Investigation|2013|232